To investigate pulse oximetry in neonates who require arterial access as represented by the clinical data recorded to manage their care.
INTRODUCTION
The use of pulse oximetry in the neonatal intensive care unit (NICU) to monitor oxygenation has been a standard of practice for many years, gaining widespread use in the mid-1980s. Studies on the accuracy and reliability of neonatal pulse oximetry have been favorable. [1] [2] [3] [4] Although pulse oximetry oxygen saturation (SpO 2 ) readings have not been accurate predictors of arterial oxygen tension (PaO 2 ), [5] [6] [7] [8] pulse oximetry in our NICU and in probably most NICUs remains a critical detector for desaturation and hypoxemia events, and as an oxygenation monitor during oxygen therapy and assisted ventilation.
The issue at hand developed from an index case in July 2001 in our NICU. An enterprising neonatal respiratory therapist presented the last shift's worth of blood gas and hemoximetry slips from a sick, ventilated, preterm infant, which were overwritten with corresponding SpO 2 values from the bedside monitor. The therapist commented, ''The saturations really don't match. What do you want me to do about it?'' A tabulation of all of the patient's arterial hemoximetry measured saturations, corresponding pulse oximetry saturation readings, and blood gas PaO 2 values demonstrated what appeared to be a systematic saturation-dependent difference between pulse and hemoximeter saturations, worse at low PaO 2 values where SpO 2 seemed to markedly overestimate the arterial measured saturation (SaO 2 ). We worried that some procedural issue in our use of pulse oximetry might have occurred, or that this patient was illustrating a measurement bias that we had not previously recognized. Hence, we began a systematic review of preanalytic, analytic, and postanalytic process and procedures to try and elucidate the problem. We did not wish to perform a controlled scientific experiment on pulse oximetry function, but rather sought to analyze available data recorded during the process of providing routine care, which might illustrate the operational performance of this technology.
Presented here are our findings from a historical evaluation, a prospective evaluation, a procedural evaluation, a verification evaluation, and an evaluation of corroborating data from NICUs at two other institutions. The relation between functional saturation and fractional oxyhemoglobin in neonates can thus be approximated as: functional saturation (fractional oxyhemoglobin/0.97) ¼ 1.03 fractional oxyhemoglobin). Pulse oximetry signal processing algorithms produce a value which is equivalent to a ''functional'' hemoximeter saturation determination. Thus, the appropriate comparison for SpO 2 is SaO 2 , the functional hemoximeter saturation. In some data sets examined for this work, the fractional oxyhemoglobin value was the one available and it was ''converted'' to functional saturation using the above formula.
METHODS
The relation between SpO 2 and SaO 2 was evaluated by calculating the bias function (SpO 2 ÀSaO 2 ) after Severinghaus et al 9 and others, 10, 11 and this was plotted against the ''gold'' standard, measured SaO 2 . Precision was indicated by the 10th and 90th data percentiles in the range of the bias.
Pulse Oximeters and Hemoximeters
The pulse oximeters for which SpO 2 data could be provided were the stand-alone or modular units available for use at the individual hospitals, except in the Prospective evaluation, where the Nellcor N-200 was provided by one of the manufacturers. The following sensors were reported as being used with these pulse oximeters: Flex II or Oxytip+ OX-AF with Datex-Ohmeda models 3700 & 3740; Nellcor Oxisensor II, I-20 or N-25 with Nellcor model N200; Nellcor Oxisensor II, I-20 or N-25 with Space Labs; LNOP-Neo with Masimo model 2000. Similarly, the blood gas analyzer or hemoximeter used for SaO 2 measurement was the one available in the NICU for patient care, except in the Verification evaluation where the IL 682 was provided by one of the manufacturers. All sites indicated that their procedure for recording the SpO 2 value was to choose the stable baseline value just prior to initiating the arterial blood gas draw. Blood gas analysis or hemoximetry was conducted in a dedicated NICU blood gas laboratory within a couple of minutes of the blood gas draw. Quality control calibrations were performed every 8 hours. Since a calculated SaO 2 via a blood gas analyzer cannot be used as a point of comparing SpO 2 accuracy, measured, not calculated, SaO 2 was reported with the corresponding pre-blood draw baseline SpO 2 . No comparison of pulse oximeter pulse rate performance was undertaken.
Historical Evaluation
An archived respiratory care blood gas data file covering the years 1991 to 1997 was de-identified and queried for all NICU records. As a matter of course, each record represented blood gas analyzer values and also contained ventilator settings, inspired oxygen fraction, SpO 2 reading (Datex-Ohmeda 3700, Madison, WI) at the time of blood gas draw, and hemoximeter (OSM-3, Radiometer, Copenhagen) measured oxyhemoglobin fraction. The queried file was then screened and cleaned for missing values and data entry errors. Functional SaO 2 was derived by converting the available arterial fractional oxyhemoglobin value, then the bias term (SpO 2 ÀSaO 2 ) was calculated and regressed against SaO 2 . 
Prospective Evaluation

Procedural Evaluation
In November 2001, an in-depth procedural evaluation was performed in the NICU to determine whether the methods being used by staff for the selection, placement, attachment and use of pulse oximeter sensors and monitors were appropriate and correct. Observations on the timing of pulse oximeter readings in correspondence to the drawing of blood for blood gases were made. Appropriate processing of blood gas samples and use of the unit's blood gas analyzer and integrated hemoximeter were also checked.
Verification Evaluation
Also in November 2001, an IRB approved study protocol was initiated, which allowed for the drawing of a small number of duplicate arterial blood gas samples in order to verify readings between two different hemoximeters (ABL 725 and IL 682). This was performed in order to rule out a hemoximeter measurement error. The paired t-test was used to compare values between hemoximeters with statistical significance determined at the pr0.05 level. The bias function was calculated for simultaneous SpO 2 readings with the Datex-Ohmeda Model 3740 pulse oximeter. No infants were receiving nitric oxide, which could have caused increased methemoglobin levels.
Evaluation of Data from Other Sites
For comparison and corroboration, colleagues at two other institutions (Primary Children's Medical Center, Salt Lake City, UT and Santa Rosa Children's Hospital, San Antonio, TX) agreed to share de-identified data collected from routine neonatal blood gas analysis and hemoximetry. The bias function was calculated and plotted for data from the two sites.
Individual Patient Analyses
Data collected for the Historical and Prospective evaluations included an unlinked patient study number. In patients where sufficient data existed that a calculation seemed feasible, individual correlation coefficients were determined. Sufficient data were defined as at least five data pairs of SpO 2 and SaO 2 , and a difference between maximum and minimum SaO 2 of at least 5. For the historical data set, the last 130 patients who met these criteria were used. In the prospective data set, 28 patients met this criterion. Individual correlation coefficients were considered significant at the pr0.05 level.
Operational Performance
In order to contrast the neonatal performance of the models of pulse oximeter for which data were available, operational performance was defined as the frequency with which at any given SaO 2 value the corresponding SpO 2 reading was within the technical accuracy specified for neonatal pulse oximetry. In general, technical specifications for pulse oximeters used in neonates suggest an accuracy of ±3 digits (1 SD) between 70 and 100% saturation. The accuracy under 70% saturation is unspecified. Operational performance (% of SpO 2 values ¼ SaO 2 ±3) was determined for the Datex-Ohmeda 3700/ 3740, Masimo 2000, Nellcor N-200, and Spacelabs pulse oximeters using data from the Prospective evaluation and the Evaluation of data from other sites.
RESULTS
Historical Evaluation
There were 31,905 records for analysis with SaO 2 values 57 to 100%. Figure 1 shows the 10th, 50th, and 90th percentiles for the saturation bias function (SpO 2 ÀSaO 2 ) versus SaO 2 for the 7-year historical data set. Although the spread in data increases with lower SaO 2 , the bias function shows a significant negative correlation with SaO 2 (r ¼ À0.67, p<0.001).
Prospective Evaluation A somewhat stronger negative correlation (r ¼ À0.86, p<0.001) of (SpO 2 ÀSaO 2 ) with SaO 2 was seen with the 4-month prospective collected data than with the historical data. There were 566 samples available for analysis on 43 patients (see Figure 2) . 
Procedural Evaluation
No systematic variances were identified in the NICU staff's performance in the selection and application of pulse oximetry sensors, in the maintenance and setting of monitors, in the recording of appropriate SpO 2 reading in conjunction with arterial blood gas draws, nor in the processing of the arterial blood sample for analysis and hemoximetry. Observations were made by respiratory therapy supervisors, outside respiratory therapy directors, and industry engineers and scientists.
Verification Evaluation
In total, 52 arterial blood samples were drawn from 10 NICU patients as part of routine blood gas monitoring and these were run simultaneously on ABL 725 and IL 682 blood gas analyzers. All SpO 2 readings were taken using the Datex-Ohmeda 3740 pulse oximeter. The average difference in hemoximeter HbO 2 paired values between the two devices was 0.07, with mean values (95% confidence limits), being 88.3 (86.4, 90.3) and 88.4 (86.9, 89.9) for the ABL 725 and IL 682 devices, respectively. The difference was not statistically significant. (SpO 2 ÀSaO 2 ) was regressed against 
Evaluation of Data from Other Sites
At one center, NICU ''A'', 95 samples were provided using data from the Spacelabs pulse oximetry module (Spacelabs Medical, Redmond, WA) and an AVL Omni 1-9 (Roche Diagnostics, Basel, Switzerland) blood gas analyzer/hemoximeter. At the second center, NICU ''B'', 168 samples were provided using data from Datex-Ohmeda series 3700 pulse oximeters and a Radiometer ABL 725 blood gas analyzer/hemoximeter. These data are presented in Figure 3 . The correlation coefficients for pulse oximetry biases in NICU ''A'' and ''B'' were: r ¼ À0.92 (p<0.001) and r ¼ À0.72 (p<0.001), respectively.
Individual Patient Analyses
In the subset of the last 130 patients with sufficient data in the Historical data set, 124 (95%) demonstrated significant negative correlations between the bias function and SaO 2 . The pulse oximeters used in these patients were the Datex-Ohmeda 3700 and 3740 models. For the 28 patients in the Prospective data set that met the data criteria, 20 (71%) demonstrated significant negative correlations between the bias function and SaO 2 . The percentages for the three (3) pulse oximeters used in this data set were: Datex-Ohmeda 3700/3740, 70% (7/10); Masimo 2000, 60% (3/5); and Nellcor N-200, 77% (10/13).
Operational Performance
Shown in Figure 4 is the operational performance of the four models of pulse oximeter that were utilized in the three NICUs.
None of the models exhibit consistent operational performance according to specifications across the range of SaO 2 of 70 to 100%. SaO 2 at peak performance varied depending on the device and ranged between an SaO 2 of 92 to 97%. Operational performance declined at SaO 2 both above and below this level. A rapid drop in operational performance was seen in all pulse oximeters as saturations decreased. For SaO 2 <88 to 90%, operational performance of the pulse oximeters was less than 50%.
DISCUSSION
Data presented here clearly indicate a significant SpO 2 bias when pulse oximetry is used in NICU patients who require arterial access. The bias worsens as true saturation values deviate from a small range (92 to 97%). As an example, at an arterial saturation of 80%, SpO 2 will typically read approximately 90%. The bias does not appear to be procedural, or related to variation in hemoximeters, or related to variation between patients. The bias does appear to be consistent across the pulse oximeter models which were used in the three NICUs, including a new generation model with advanced low perfusion and motion detection algorithms that has recently been clinically evaluated. 12 The poor operational performance of pulse oximetry seen in these data seems at a level inconsistent with their At these sites as well, the pulse oximetry bias is seen to worsen as saturation values decrease. current perceived importance, role and use in the NICU. These results suggest that in the range of SaO 2 approaching 100%, use of the pulse oximeters tested could lead to overtreatment with supplemental oxygen, and in the range of SaO 2 approaching 70%, a neonate could be under treated.
Although there are not a large number of publications that address the topic, pulse oximeter readings at low arterial saturation values have previously been reported in different patient populations to either underestimate, overestimate, or accurately represent true saturation. In healthy adult volunteers breathing sub ambient oxygen concentrations, pulse oximetry underestimated arterial saturation. 9 For pediatric patients with cyanotic heart disease, pulse oximetry overestimated true saturations at levels below 80%. 13, 14 Other reports suggest that infants and children with low saturation levels have SpO 2 values that appeared to adequately represent SaO 2 . 15, 16 In the neonatal population, a 1988 report by Fanconi 10 analyzed 160 paired values in 20 mostly term/near-term NICU patients who had initial SaO 2 < 65% using a first-generation pulse oximeter. He found that SpO 2 overestimated SaO 2 at low saturations and underestimated at high saturations. In addition, the bias did not appear to be correlated to characteristics of the patient sample (i.e., single patient, blood pressure, heart rate, temperature, or medical therapy). Our data would agree with this last observation, as nearly all of the patients who had five or more blood gases demonstrated the poor correlation. A 1989 report by Praud et al., 11 analyzed 112 comparisons (60 neonates and 11 infants) of pulse oximeter and arterial oxygen saturation values where the latter ranged from 80 to 100%.
11 SpO 2 overestimated SaO 2 as SaO 2 decreased and the bias function (SpO 2 ÀSaO 2 ) exhibited a significant negative correlation to SaO 2 , r ¼ À0.64 (p<0.01). Although the Praud et al., report does not contain arterial saturation values as low as seen in the Fanconi data or in the current data, the magnitude of the negative correlation is similar. Of concern is that the bias reported in these early papers for first-generation pulse oximeters appears to continue to be present in second-and third-generation devices as seen in our current data.
The etiology of this pulse oximetry bias is unclear. Although our Procedural evaluation did not result in any obvious explanations, there may be some not-yet understood correlation between our procedural methods and the observed bias that will require further study. Bias from patient motion artefact is commonly attributed to signal loss or corruption and often causes SpO 2 to read low rather than high. Hypoperfusion can independently also introduce a pulse oximetry bias. 17 Like motion artefact, hypoperfusion will generally cause the SpO 2 to read low rather than high. Bias from motion artefact and hypoperfusion would occur in a direction opposite to that seen in the current study. Lastly, inconsistencies in readings between hemoximeters have been reported at very low saturation ranges. 18 Since different hemoximeters/blood gas analyzers were used at the three sites for the current data, it is possible that part of the noted bias might be because of this type of systematic bias, and also might help explain why the slope of the bias appears to vary between the various data sets. However, within site, the bias existed regardless of the model of blood analyzer.
Inaccuracy at low saturations may be an inherent problem with the standard dual wavelength pulse oximeter when attempting to measure very low saturations, such as with fetal oxygen saturation monitoring. 19 Adjustments have been proposed in emitter wavelength selection to improve device performance within these low oxygen saturation ranges. 20 Similar modifications may be required in order to improve performance of pulse oximetry for neonatal use. Pulse oximeters used in the NICU have historically been calibrated by industry using healthy adults. However, compared to a healthy adult, blood characteristics in peripheral tissue may be quite different in the neonatal patient with cardiopulmonary disease who requires arterial access. These conditions may render the standard calibration inappropriate. In fact, in situ calibration technology may need to be developed in order to provide patient specific calibrations that can change with the disease course. If more than two wavelength emitters become necessary in order to broaden the range of pulse oximetry accuracy, Figure 4 . Pulse oximeter operational performance. Operational performance was defined as the percent of pulse oximetry readings at each SaO 2 value where the pulse oximeter value is within the devicespecified accuracy for neonates, that is, SpO 2 ¼ SaO 2 ±3. Displayed here are polynomial curves fitted to the operational performance data for the four models of pulse oximeters for which data are available. Operational performance as a percentage is plotted against SaO 2 . Since SaO 2 ±3 ¼ SaO 2 ±1SD, operational performance for the devices should be at or above 68% (horizontal line) across the range of SaO 2 of values. No pulse oximeter model shows instrument performance which is consistent except within a narrow range. Peak performance occurs between 92 and 97%, depending on device. There is declining performance both above and below this narrow range. Operational performance falls to 50% by an SaO 2 of 88 to 90% in all four models, meaning that one-half the time the SpO 2 reading deviates from the true saturation by more than 3 units of saturation percentage. pulse spectrophotometry could become the basis for future generations of devices. 21 This project by no means was intended to be an exhaustive study of neonatal pulse oximetry, but rather a ''snapshot'' of clinical performance from available clinical data. Other manufacturers and models of pulse oximeters are routinely used in NICUs and these devices may have operational characteristics different than seen in these data. Pulse oximetry experience in other NICUs may also be different. However, the question of operational performance of pulse oximetry is a very important one, and one that must be examined in much more depth by manufacturers. Isolated calibration and small quality control studies apparently do not correlate with the operational performance that clinicians must rely upon. One would also hope that the accuracy of SpO 2 could be improved to much better than ±3 (1 SD). Values within ±2 occurring 90% of the time across the entire 70 to 100% saturation range would be a much more clinically appropriate goal for neonatal pulse oximetry monitoring.
In summary, a discrepancy between pulse oximetry and hemoximetry derived arterial saturation measurements in an NICU patient prompted an evaluation of our pulse oximetry use and the accuracy of these readings. All data examined indicate a systematic bias in currently used dual wavelength pulse oximetry devices, with pulse oximetry generally overestimating hemoximetry arterial saturations at low saturations and underestimating at high saturations. The bias increases as saturations decrease. NICU patients who appear to have adequate arterial saturation by pulse oximetry may in fact have actual saturations which are outside of acceptable limits. Until improvements in pulse oximetry monitoring can be made that correct this measurement bias, adjustments to supplemental oxygen and ventilator settings in the NICU patient must be based on and re-evaluated by arterial blood gas analysis and hemoximetry.
